M&T Bank
DNA icon

M&T Bank’s Ginkgo Bioworks DNA Stock Holding History

M&T Bank’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-898
Closed -$11.6K – 1645
2024
Q2 		$11.6K Sell
898
-321
-26% -$9.58K ﹤0.01% 1567
2024
Q1 		$56.2K Buy
1,219
+96
+9% +$4.97K ﹤0.01% 1566
2023
Q4 		$75.8K Buy
1,123
+22
+2% +$1.35K ﹤0.01% 1566
2023
Q3 		$79.7K Buy
1,101
+136
+14% +$10.9K ﹤0.01% 1510
2023
Q2 		$71.4K Buy
965
+169
+21% +$10K ﹤0.01% 1555
2023
Q1 		$42.8K Sell
796
-155
-16% -$9.82K ﹤0.01% 1588
2022
Q4 		$64.1K Buy
951
+105
+12% +$9.66K ﹤0.01% 1579
2022
Q3 		$104K Buy
846
+84
+11% +$10K ﹤0.01% 1503
2022
Q2 		$72K Buy
+762
New +$92.9K ﹤0.01% 1491

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

M&T Bank's DNA Position: Q3 2024 in Review

M&T Bank sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 898 shares — an estimated $11.6K sold.

M&T Bank first reported a position in DNA in Q2 2022 and held it in 9 quarters. The position peaked at $104K in Q3 2022. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • M&T Bank reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • M&T Bank sold 898 Ginkgo Bioworks shares in Q3 2024, an estimated $11.6K.
  • M&T Bank first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 9 quarters.
  • M&T Bank's Ginkgo Bioworks position peaked at $104K in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on M&T Bank's 13F filing for Q3 2024, filed 15 Nov 2024.